Cargando…

Antimicrobial efficacy of aqueous ozone in combination with short chain fatty acid buffers

BACKGROUND: Mitigating surface contamination by microbes such as S. aureus, Salmonella enterica, or Klebsiella pneumoniae, is an ongoing problem in hospital and food production environments. AIM: To determine whether addition of buffering solution to source water used for manufacture of aqueous ozon...

Descripción completa

Detalles Bibliográficos
Autores principales: Britton, Holly C., Draper, Michael, Talmadge, James E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336142/
https://www.ncbi.nlm.nih.gov/pubmed/34368688
http://dx.doi.org/10.1016/j.infpip.2019.100032
_version_ 1783733266430296064
author Britton, Holly C.
Draper, Michael
Talmadge, James E.
author_facet Britton, Holly C.
Draper, Michael
Talmadge, James E.
author_sort Britton, Holly C.
collection PubMed
description BACKGROUND: Mitigating surface contamination by microbes such as S. aureus, Salmonella enterica, or Klebsiella pneumoniae, is an ongoing problem in hospital and food production environments. AIM: To determine whether addition of buffering solution to source water used for manufacture of aqueous ozone increases ozone efficacy against ozone-resistant bacterial species. METHODS: Antimicrobial effects of aqueous ozone were studied in combination with acetate, propionate, or butyrate short chain fatty acids (SCFA) as well as citrate or oxalate buffer formulations against Staphylococcus aureus on glass coupons. Aqueous ozone combined with an acetate buffer was also evaluated against Salmonella enterica and Klebsiella pneumoniae. FINDINGS: The acetate, propionate, and butyrate buffered aqueous ozone combinations had a significant 3–4 log reduction of S. aureus (P<0.05) colony forming unit (CFU), while citrate or oxalate buffered aqueous ozone, although statistically significant versus buffer alone, had less activity. Treatment of S. aureus, S. enterica, or K. pneumoniae with acetate buffered aqueous ozone also resulted in a 4 log or greater reduction in CFUs post-treatment for all three species, versus treatment with water alone. CONCLUSIONS: All buffer systems tested had a significantly greater reduction in CFUs following treatment with the combination of buffer and ozone, compared to treatment with buffer or ozone individually, which has not been previously reported for hard surfaces. These results suggest that SCFA buffered ozone has greater anti-bacterial activity relative to either agent alone, and the activity is independent of the buffering activity. Thus, these formulations have potential to sanitize without residues, using an environmentally conscious formulation.
format Online
Article
Text
id pubmed-8336142
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83361422021-08-05 Antimicrobial efficacy of aqueous ozone in combination with short chain fatty acid buffers Britton, Holly C. Draper, Michael Talmadge, James E. Infect Prev Pract Original Research Article BACKGROUND: Mitigating surface contamination by microbes such as S. aureus, Salmonella enterica, or Klebsiella pneumoniae, is an ongoing problem in hospital and food production environments. AIM: To determine whether addition of buffering solution to source water used for manufacture of aqueous ozone increases ozone efficacy against ozone-resistant bacterial species. METHODS: Antimicrobial effects of aqueous ozone were studied in combination with acetate, propionate, or butyrate short chain fatty acids (SCFA) as well as citrate or oxalate buffer formulations against Staphylococcus aureus on glass coupons. Aqueous ozone combined with an acetate buffer was also evaluated against Salmonella enterica and Klebsiella pneumoniae. FINDINGS: The acetate, propionate, and butyrate buffered aqueous ozone combinations had a significant 3–4 log reduction of S. aureus (P<0.05) colony forming unit (CFU), while citrate or oxalate buffered aqueous ozone, although statistically significant versus buffer alone, had less activity. Treatment of S. aureus, S. enterica, or K. pneumoniae with acetate buffered aqueous ozone also resulted in a 4 log or greater reduction in CFUs post-treatment for all three species, versus treatment with water alone. CONCLUSIONS: All buffer systems tested had a significantly greater reduction in CFUs following treatment with the combination of buffer and ozone, compared to treatment with buffer or ozone individually, which has not been previously reported for hard surfaces. These results suggest that SCFA buffered ozone has greater anti-bacterial activity relative to either agent alone, and the activity is independent of the buffering activity. Thus, these formulations have potential to sanitize without residues, using an environmentally conscious formulation. Elsevier 2019-12-16 /pmc/articles/PMC8336142/ /pubmed/34368688 http://dx.doi.org/10.1016/j.infpip.2019.100032 Text en © 2019 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research Article
Britton, Holly C.
Draper, Michael
Talmadge, James E.
Antimicrobial efficacy of aqueous ozone in combination with short chain fatty acid buffers
title Antimicrobial efficacy of aqueous ozone in combination with short chain fatty acid buffers
title_full Antimicrobial efficacy of aqueous ozone in combination with short chain fatty acid buffers
title_fullStr Antimicrobial efficacy of aqueous ozone in combination with short chain fatty acid buffers
title_full_unstemmed Antimicrobial efficacy of aqueous ozone in combination with short chain fatty acid buffers
title_short Antimicrobial efficacy of aqueous ozone in combination with short chain fatty acid buffers
title_sort antimicrobial efficacy of aqueous ozone in combination with short chain fatty acid buffers
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336142/
https://www.ncbi.nlm.nih.gov/pubmed/34368688
http://dx.doi.org/10.1016/j.infpip.2019.100032
work_keys_str_mv AT brittonhollyc antimicrobialefficacyofaqueousozoneincombinationwithshortchainfattyacidbuffers
AT drapermichael antimicrobialefficacyofaqueousozoneincombinationwithshortchainfattyacidbuffers
AT talmadgejamese antimicrobialefficacyofaqueousozoneincombinationwithshortchainfattyacidbuffers